Robert Zaczek
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$7.5MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $7.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Mar 25, 2019 | NIH | SBIR Phase II Phase 1 Clinical Evaluation of NP10679, a GluN2B Selective, Context-Dependent NMDA Receptor Inhibitor for Subarachnoid Hemorrhage | $125K | NEUROP, INC. |
| Aug 21, 2018 | NIH | SBIR Phase II Phase 1 Clinical Evaluation of NP10679, a GluN2B Selective, Context-Dependent NMDA Receptor Inhibitor for Subarachnoid Hemorrhage | $1.3M | NEUROP, INC. |
| Jul 13, 2018 | NIH | STTR Phase I Preclinical assessment of the GluN2B inhibitor clinical candidate NP10679 as a medication to prevent opiate abuse relapse | $301K | NEUROP, INC. |
| Aug 1, 2017 | NIH | SBIR Phase II Phase 1 Clinical Evaluation of NP10679, a GluN2B Selective,Context-Dependent NMDA Receptor Inhibitor for Subarachnoid Hemorrhage | $3.6M | NEUROP, INC. |
| Jul 18, 2017 | NIH | SBIR Phase II Phase 1 Clinical Evaluation of NP10679, a GluN2B Selective, Context-Dependent NMDA Receptor Inhibitor for Subarachnoid Hemorrhage | $2.2M | NEUROP, INC. |
Peer ranks
Federal funding#126
Awards as PI#417
Patents#273
Companies
- NEUROP, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.